Here's the live share price of Corona Remedies along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Corona Remedies | -1.75 | 3.64 | 18.56 | 25.98 | 43.40 | 12.77 | 7.48 |
| Sun Pharmaceutical Industries | -2.03 | 2.42 | 6.25 | 14.34 | 21.92 | 18.89 | 19.84 |
| Divi's Laboratories | 2.38 | 21.83 | 23.10 | 34.86 | 34.50 | 28.25 | 10.95 |
| Torrent Pharmaceuticals | -2.96 | 2.01 | 13.61 | 23.94 | 37.68 | 34.14 | 26.36 |
| Cipla | -0.06 | 1.35 | 8.01 | 9.65 | -1.30 | 6.36 | 9.89 |
| Zydus Lifesciences | -1.00 | -3.27 | 18.63 | 20.81 | 17.97 | 19.40 | 13.74 |
| Lupin | -2.23 | -5.22 | -4.06 | 7.32 | 21.26 | 29.71 | 15.79 |
| Mankind Pharma | -1.25 | -3.65 | 2.68 | 17.10 | -4.05 | 10.60 | 11.36 |
| Laurus Labs | 2.14 | 25.61 | 53.76 | 88.11 | 121.31 | 66.72 | 21.42 |
| Dr. Reddy's Laboratories | 2.13 | -13.43 | -10.32 | -8.07 | -2.39 | 1.33 | 4.01 |
| Aurobindo Pharma | 5.17 | 4.93 | 12.34 | 38.27 | 55.33 | 24.16 | 13.36 |
| Biocon | 1.02 | 5.68 | 12.39 | 15.00 | 17.94 | 18.08 | 2.38 |
| Alkem Laboratories | -1.90 | -0.38 | 0.94 | -1.80 | 15.69 | 10.94 | 9.88 |
| Glenmark Pharmaceuticals | 2.40 | 1.04 | -3.54 | 15.79 | 10.84 | 41.01 | 31.10 |
| Abbott India | 0.06 | 4.08 | 4.16 | 1.18 | -15.15 | 5.10 | 9.68 |
| Anthem Biosciences | 3.87 | 9.52 | 7.85 | 24.79 | 11.94 | 4.78 | 2.84 |
| GlaxoSmithKline Pharmaceuticals | -2.01 | 8.20 | 4.88 | 3.54 | -2.95 | 22.96 | 9.76 |
| Ipca Laboratories | -0.70 | -3.23 | 11.36 | 19.51 | 24.74 | 23.09 | 8.61 |
| Ajanta Pharma | 0.29 | 4.90 | 12.99 | 21.74 | 33.05 | 25.85 | 17.93 |
| Gland Pharma | 4.42 | 2.51 | 39.75 | 38.72 | 33.61 | 24.85 | -8.35 |
Source: Dion Global
Over the last one year, Corona Remedies has gained 43.40% compared to peers like Sun Pharmaceutical Industries (21.92%), Divi's Laboratories (34.50%), Torrent Pharmaceuticals (37.68%). From a 5 year perspective, Corona Remedies has underperformed peers relative to Sun Pharmaceutical Industries (19.84%) and Divi's Laboratories (10.95%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,093.46 | 2,110.97 |
| 10 | 2,083.46 | 2,097.78 |
| 20 | 2,059.49 | 2,064.09 |
| 50 | 1,905.55 | 1,954.25 |
| 100 | 1,770.98 | 1,820.32 |
| 200 | 1,300.03 | 0 |
Source: Dion Global
In the latest quarter, Corona Remedies remained same as its previous close in promoter holding, while DII stake increased to 12.90%, FII holding rose to 3.63%, and public shareholding moved down to 14.47% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 23,33,333 | 0.43 | 459.04 | |
| 14,00,325 | 2.06 | 275.49 | |
| 7,00,000 | 1 | 137.71 | |
| 5,39,225 | 0.95 | 106.08 | |
| 4,62,035 | 0.63 | 90.9 | |
| 2,79,353 | 1.28 | 54.96 | |
| 2,08,425 | 1.81 | 41 | |
| 1,84,856 | 0.42 | 36.37 | |
| 1,61,861 | 0.96 | 31.84 | |
| 1,16,970 | 2.28 | 23.01 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Aug 03, 2026, 09:51 PM IST IST | Corona Remedies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Aug 01, 2026, 01:05 AM IST IST | Corona Remedies - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Jul 31, 2026, 11:13 PM IST IST | Corona Remedies - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Jul 31, 2026, 10:58 PM IST IST | Corona Remedies - Unaudited Financial Results For The First Quarter And Three Months Ended June 30, 2026 |
| Jul 31, 2026, 10:50 PM IST IST | Corona Remedies - Board Meeting Outcome for Outcome Of Board Meeting |
Source: Dion Global
Corona Remedies Ltd. is a Public Limited Listed company incorporated on 27/08/2004 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24231GJ2004PLC044656 and registration number is 044656. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1403.18 Cr. and Equity Capital is Rs. 61.16 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Corona Remedies is ₹2,060.90 as on Aug 07, 2026.
The Corona Remedies is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Corona Remedies is ₹12,604.48 Cr as on Aug 07, 2026.
Today’s highest and lowest price of Corona Remedies are ₹2,085.65 and ₹2,031.65.
The 52-week high/low is the highest and lowest price at which Corona Remedies stock has traded in the past 52-week or nearly a year. The 52-week high of Corona Remedies is ₹2,261.40 and 52-week low of Corona Remedies is ₹1,336.95 as on Aug 07, 2026.
The Corona Remedies has shown returns of 0.73% over the past day, 3.64% for the past month, 18.56% over 3 months, 43.4% over 1 year, 12.77% across 3 years, and 7.48% over 5 years.
P/E ratio of and PB ratio of Corona Remedies are 63.33 and 16.88 on Aug 07, 2026. While the company gives a dividend yield of 0.49 per annum.
Source: Dion Global